Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Here's What to Expect From Insulet's Next Earnings Report

With a market cap of $17.2 billion, Insulet Corporation (PODD) is a leading developer and manufacturer of the Omnipod Insulin Management System, an innovative, tubeless, and easy-to-use continuous insulin delivery solution for people with insulin-dependent diabetes. It also partners with pharmaceutical and biotechnology firms to customize its Omnipod platform for the subcutaneous delivery of various drugs across different therapeutic areas.

The Acton, Massachusetts-based company is expected to release its fiscal Q1 2025 earnings results after the market closes on Thursday, May 8. Ahead of this event, analysts expect PODD to report an adjusted EPS of $0.81, up nearly 11% from $0.73 in the prior year's quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on another occasion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.